Chiara Biagioni

Prato, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

The genomic landscape of HER2 negative metastatic breast cancer with loss of estrogen and progesterone receptors.

The genomic landscape of HER2 negative metastatic breast cancer with loss of estrogen and progesterone receptors.

Journal: Breast (Edinburgh, Scotland)

Published: October 07, 2025

Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network.

Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network.

Journal: ESMO open

Published: August 19, 2025

A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.

A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.

Journal: Genome medicine

Published: August 01, 2025

Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).

Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 21, 2025

Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer.

Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer.

Journal: NPJ breast cancer

Published: September 19, 2024

Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial.

Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 06, 2024

Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Journal: JCO precision oncology

Published: March 01, 2024

MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.

MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.

Journal: Briefings in bioinformatics

Published: November 16, 2022

Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.

Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.

Journal: Translational oncology

Published: June 02, 2022

PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer.

PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer.

Journal: NPJ breast cancer

Published: June 30, 2021

A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting.

A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting.

Journal: Cancers

Published: April 15, 2021

Charting differentially methylated regions in cancer with Rocker-meth.

Charting differentially methylated regions in cancer with Rocker-meth.

Journal: Communications biology

Published: March 27, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026